Olivier Bouchard is an Industry Advisor based in France, Paris and is part of the Health and Life Sciences Practice at SAS. He has been at SAS for several years with over 20+ years in the pharmaceutical industry, supporting various software solutions. Olivier is a strong believer in the power of AI and Analytics and enjoys transforming Life Sciences and Healthcare markets with insights derived from data. He is also an active member of the Life Sciences EMEA GTM team to ensure consistent branding and messaging across Life Sciences accounts. He strongly believes that AI and Analytics will make a better world for Patients, by bringing innovative therapies and putting the Patient at the convergence of Life Sciences & Healthcare Industries. Olivier Bouchard is an expert in transforming health and Life Sciences markets using the power of insights from data.
For years, digital transformation in clinical R&D has primarily focused on automating existing processes—often reinforcing long‑established functional silos such as data management, statistical programming, analysis, and reporting.
Artificial Intelligence represents a far more structural shift. Rather than simply accelerating current workflows, AI challenges how organizations are designed, governed, and held accountable.
In this joint session, Johnson & Johnson and SAS explore how AI enables a move from siloed execution to an orchestration‑based model, where human experts leverage specialized AI agents across data management, statistical programming, analysis, and reporting.
The discussion highlights how governed, auditable AI platforms make this model operational at scale, while addressing emerging risks and regulatory expectations. A forward‑looking perspective on how health authorities approach AI adoption completes the session.
This session is for leaders looking to understand the fundamental shift in value, from manual production to judgment‑driven decision‑making, coordination, and transparency.